In the nearly four years since GlaxoSmithKline looked to revamp the way it hires and pays for outside legal services, the pharmaceutical giant has saved tens of millions of dollars in legal fees.

Those savings are expected to only increase with GSK’s growing use of online reverse auctions for any matter over a certain nominal fee.